29 Jun 2015 10:56
RNS Number : 4966R
4d Pharma PLC
29 June 2015
4D pharma plc
Result of annual general meeting
At the annual general meeting of 4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live biotherapeutics, held earlier today, all resolutions put to shareholders were duly passed.
For further information please contact:
4D | + 44 (0) 161 837 6205 |
Duncan Peyton, Chief Executive Officer
| |
Zeus Capital Limited - Nomad and Broker | |
Dan Bate/Ross Andrews | +44 (0) 161 831 1512 |
Dominic Wilson | +44 (0) 20 7533 7727 |
This information is provided by RNS
The company news service from the London Stock Exchange